...
首页> 外文期刊>AJNR. American journal of neuroradiology >Microcatheter to recanalization (procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: when do we stop?
【24h】

Microcatheter to recanalization (procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: when do we stop?

机译:微导管再通(手术时间)可预测急性缺血性卒中患者的血管内治疗结果:何时停止?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endovascular treatment for acute ischemic stroke consists of various mechanical and pharmacologic modalities used for recanalization of arterial occlusions. We performed this study to determine the relationship among procedure time, recanalization, and clinical outcomes in patients with acute ischemic stroke undergoing endovascular treatment.We analyzed data from consecutive patients with acute ischemic stroke who underwent endovascular treatment during a 6-year period. Demographic characteristics, NIHSS score before and 24 hours after the procedure, and discharge mRS score were ascertained. Procedure time was defined by the time interval between microcatheter placement and recanalization or completion of the procedure. We estimated the procedure time after which favorable clinical outcome was unlikely, even after adjustment for age, time from symptom onset, and admission NIHSS scores.We analyzed 209 patients undergoing endovascular treatment (mean age, 65 ± 16 years; 109 [52%] men; mean admission/preprocedural NIHSS score, 15.3 ± 6.8). Complete or partial recanalization was observed in 176 (84.2%) patients, while unfavorable outcome (mRS 3-6) was observed in 138 (66%) patients at discharge. In univariate analysis, patients with procedure time ≤30 minutes had lower rates of unfavorable outcome at discharge compared with patients with procedure time ≥30 minutes (52.3% versus 72.2%, P = .0049). In our analysis, the rates of favorable outcomes in endovascularly treated patients after 60 minutes were lower than rates observed with placebo treatment in the Prourokinase for Acute Ischemic Stroke Trial. In logistic regression analysis, unfavorable outcome was positively associated with age (P = .0012), admission NIHSS strata (P = .0017), and longer procedure times (P = .0379).Procedure time in patients with acute ischemic stroke appears to be a critical determinant of outcomes following endovascular treatment. This highlights the need for procedure time guidelines for patients being considered for endovascular treatment in acute ischemic stroke.
机译:急性缺血性卒中的血管内治疗包括多种用于动脉闭塞再通的机械和药理学方法。我们进行了这项研究,以确定接受血管内治疗的急性缺血性中风患者的手术时间,再通气和临床结局之间的关系。我们分析了连续的急性缺血性中风患者在6年内接受血管内治疗的数据。确定人口统计学特征,术前和术后24小时的NIHSS评分以及出院mRS评分。程序时间由微导管放置与再通或程序完成之间的时间间隔定义。我们估算了手术时间,即使调整了年龄,症状发作时间和入院NIHSS评分后,仍不可能取得良好的临床效果。我们分析了接受血管内治疗的209例患者(平均年龄65±16岁; 109 [52%]男性;平均入院/术前NIHSS评分为15.3±6.8)。出院时有176例(84.2%)患者完全或部分再通,而138例(66%)患者则观察到不良转归(mRS 3-6)。在单因素分析中,与手术时间≥30分钟的患者相比,手术时间≤30分钟的患者出院时不良结局发生率较低(52.3%对72.2%,P = .0049)。在我们的分析中,经血管内治疗的患者在60分钟后的良好结局率低于在Prourokinase进行的急性缺血性卒中试验中观察到的安慰剂治疗率。在逻辑回归分析中,不良结局与年龄(P = .0012),入院NIHSS分层(P = .0017)和更长的手术时间(P = .0379)成正相关。急性缺血性卒中患者的手术时间似乎与是血管内治疗后疗效的关键决定因素。这突显了对于考虑在急性缺血性卒中中进行血管内治疗的患者制定手术时间指南的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号